Edition:
United Kingdom

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

14.55EUR
23 May 2018
Change (% chg)

€0.03 (+0.21%)
Prev Close
€14.52
Open
€14.60
Day's High
€14.67
Day's Low
€14.41
Volume
125,595
Avg. Vol
220,612
52-wk High
€14.84
52-wk Low
€10.02

Chart for

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.92
Market Cap(Mil.): €908.83
Shares Outstanding(Mil.): 71.84
Dividend: --
Yield (%): --

Financials

  FAGRO.BR Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -0.20 -- --
ROI: -2.41 14.84 14.38
ROE: -10.76 16.34 16.07

BRIEF-Fagron Reports Q1 Turnover At 109.1 Million Euros

* Q1 TURNOVER EUR 109.1 MILLION VERSUS EUR 109.0 MILLION YEAR AGO

12 Apr 2018

French and Benelux stocks-Factors to watch on April 4

April 4 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

04 Apr 2018

BRIEF-Humco And Fagron To Combine For Up To 70 Million Dollars

* ‍GREGORY PULIDO, HUMCO'S CHAIRMAN AND CHIEF EXECUTIVE OFFICER, WILL TRANSITION TO ROLE OF EXECUTIVE CHAIRMAN​

03 Apr 2018

BRIEF-Fagron Acquires Humco in United States

* FAGRON STRENGTHENS STRATEGIC POSITION IN USA THROUGH HIGHLY COMPLEMENTARY ACQUISITION OF HUMCO

03 Apr 2018

BRIEF-Fagron FY Rebitda Increased 5.7% To 95.7 Million Euros

* REG-FAGRON TURNOVER INCREASED BY 3.6% TO € 436.9 MILLION AND NET PROFIT INCREASED TO € 47.0 MILLION

07 Feb 2018

BRIEF-Cannimed Therapeutics Announces Cannabis Distribution Agreement With Fagron NV

* CANNIMED THERAPEUTICS INC. ANNOUNCES STRATEGIC INTERNATIONAL CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV

10 Jan 2018

Earnings vs. Estimates